The reduction of IKKβ expression partly protects mice from obesity-induced insulin resistance, and the inhibition of this kinase achieved by high doses of salicylates has been shown to improve insulin sensitivity in humans and other experimental models [16]. Here, INS is linked to obesity disorder.